Summit Therapeutics (SUMM) News Today → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free SUMM Stock Alerts GBX 20.50 0.00 (0.00%) (As of 02/21/2020) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 5:09 PM | tmcnet.comBiora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 6, 2024 | seekingalpha.comSummit Therapeutics' Ivonescimab: Strong Buy Its Dual-Action Approach To CancerMay 2, 2024 | seekingalpha.comSummit Therapeutics Inc. (SMMT) Q1 2024 Earnings Call TranscriptMay 2, 2024 | finance.yahoo.comQ1 2024 Summit Therapeutics Inc Earnings CallApril 30, 2024 | bizjournals.comRxLightning, BehaVR founders reflect on becoming CEOsApril 29, 2024 | afr.com‘The right time to go’: Maskell to leave Melbourne UniversityApril 27, 2024 | msn.comHunt calls Dorneywood summit to boost flagging UK stock marketApril 23, 2024 | markets.businessinsider.comAspen Ideas: Health Announces Global Health Experts to Speak at Annual SummitApril 18, 2024 | finance.yahoo.comRenibus Therapeutics Announces Oral Presentation on RBT-1 at the European Association for Cardio-Thoracic Surgery (EACTS) 2nd Innovation SummitApril 16, 2024 | finance.yahoo.com2024 DTA Summit Agenda is LIVE!!April 13, 2024 | investing.comSummit Therapeutics appoints genomics expert to boardApril 9, 2024 | msn.comIllumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeedApril 8, 2024 | msn.comCarisma Therapeutics to Present at Upcoming Healthcare ConferencesApril 5, 2024 | finance.yahoo.comIn coordination with DoH J.P. Morgan's Life Sciences Private Capital announces Life Sciences Innovation Summit 2024 finalists ahead of ADGHWApril 4, 2024 | finance.yahoo.comNorthStar Medical Radioisotopes Announces Participation in Upcoming 2024 Jefferies Radiopharma Innovation SummitApril 2, 2024 | msn.comFrance’s Superprod Group Acquires Luxembourg Animation Duo Studio 352 & Mélusine ProductionsApril 2, 2024 | finance.yahoo.comSpotlighting Excellence: Keiretsu Forum Curates Premiere Investment Opportunities for the 2024 Angel Capital Association Innovation Funders ShowcaseMarch 29, 2024 | msn.comWhy Summit Therapeutics Stock Crushed the Market This WeekMarch 28, 2024 | benzinga.comAkeso Marks Profit Milestone With Swift Rights IssueMarch 27, 2024 | finance.yahoo.comCoave Therapeutics to Present at Upcoming ConferencesMarch 27, 2024 | msn.comLukashenko says concert hall attackers first headed for Belarus, contradicting PutinMarch 27, 2024 | msn.comPolice probe possible bomb threat at Simi Valley surgery centerMarch 27, 2024 | markets.businessinsider.comAnalysts Eye Summit Therapeutics' Ivonescimab As Potential Challenger To Merck's Keytruda in Lung Cancer TreatmentMarch 26, 2024 | finanznachrichten.deEnveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023March 26, 2024 | seekingalpha.comWall Street Breakfast Podcast: Lucid Group Secures $1B InvestmentMarch 25, 2024 | finance.yahoo.comSummit Therapeutics Insiders Up US$5.1m On US$5.05m InvestmentMarch 22, 2024 | stockhouse.comPromising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024March 21, 2024 | msn.comScientists Working on Drug to Indefinitely Delay MenopauseMarch 20, 2024 | msn.comNew menopause prevention drug could delay onset, boost women’s longevityMarch 18, 2024 | finance.yahoo.comRS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation SummitMarch 15, 2024 | finance.yahoo.comCRBP Mar 2024 30.000 putMarch 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Cresco Labs (OtherCRLBF)March 13, 2024 | markets.businessinsider.comTVM Capital Life Science to Participate in LSI USA ’24 Emerging Medtech Summit 2024March 13, 2024 | msn.com'Superhero' team of experts in health, longevity to convene at West Palm's Livelong SummitMarch 12, 2024 | finance.yahoo.comFavorable Results From Dermacyte® Matrix Research Study Published in March Issue of Journal of Wound CareMarch 11, 2024 | tmcnet.comAbundance360 to Host "Great AI Debate" SummitMarch 11, 2024 | finanznachrichten.deLexicon Pharmaceuticals, Inc.: Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business UpdateMarch 11, 2024 | markets.businessinsider.comLexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business UpdateMarch 5, 2024 | finanznachrichten.deRadiance Therapeutics to Attend LSI USA '24 Emerging Medtech Summit in Dana Point, CAMarch 1, 2024 | markets.businessinsider.comNurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global SummitFebruary 26, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMTFebruary 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for Crispr Therapeutics AG on Robust Pipeline and Expanding Global ReachFebruary 22, 2024 | msn.comRussia says it shipped 200,000 tonnes of free grain to six African countriesFebruary 20, 2024 | msn.comSummit Therapeutics stock plunges 28% amid financial updatesFebruary 20, 2024 | msn.comSummit Therapeutics Non-GAAP EPS of -$0.04February 18, 2024 | ca.finance.yahoo.comCRSP Jan 2026 80.000 callFebruary 18, 2024 | finance.yahoo.comSMMT Jul 2024 6.000 callFebruary 17, 2024 | finance.yahoo.comSMMT Mar 2024 6.000 callFebruary 16, 2024 | money.usnews.comSummit Therapeutics IncFebruary 15, 2024 | tmcnet.comCRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SUMM and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. SUMM Media Mentions By Week SUMM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SUMM News Sentiment▼0.000.49▲Average Medical News Sentiment SUMM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SUMM Articles This Week▼12▲SUMM Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SUMM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Oxford Cannabinoid Technologies News Today Physiomics News Today ReNeuron Group News Today ValiRx News Today genedrive News Today Fusion Antibodies News Today IQ-AI News Today Evgen Pharma News Today IXICO News Today Surgical Innovations Group News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SUMM) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist My Default Watchlist Adding Summit Therapeutics PLC You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.